Carlsmed (CARL) Stock Price
Carlsmed Price
For Carlsmed, the net margin of -91.5% is up versus -137.2% a few years ago. The consensus 12-month price target for Carlsmed is 18.50 USD, about 31.2% above where the stock trades today. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.
Carlsmed stock price
Carlsmed business model & stock analysis
Frequently asked questions about Carlsmed
Analysts currently set an average price target of 18.50 USD for the Carlsmed stock (median: 18.50 USD), implying +31.2 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the Carlsmed stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Carlsmed to generate revenue of 76.71 M USD and earnings per share of -1.46 USD.
Converted at the current exchange rate, the Carlsmed share trades at 12.53 EUR (14.10 USD).
The expected revenue of Carlsmed is 76.71 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Carlsmed is -38.65 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Carlsmed is currently -9.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Carlsmed stock.
The price-to-sales ratio (P/S) of Carlsmed is currently 4.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Carlsmed stock.
The Eulerpool Quality Score for Carlsmed is 2/10.
The ISIN of Carlsmed is US14280C1053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Carlsmed is CARL. The ticker symbol is used to trade Carlsmed shares on the stock exchange.
Carlsmed stock
Carlsmed Peer Group
All fundamentals and in-depth analysis of Carlsmed
Our stock analysis for Carlsmed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carlsmed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.